10-Q: JBT Marel Q3 2025: Revenue Soars Post-Marel Acquisition

JBT Marel Corporation reports significant revenue growth in Q3 2025 driven by the Marel acquisition, despite a net loss for the nine-month period.

Summary

• Total revenue for the three months ended September 30, 2025, increased by $547.5 million (120.6%) to $1,001.3 million, compared to $453.8 million in the same period of 2024.
• Total revenue for the nine months ended September 30, 2025, increased by $1,541.8 million (123.5%) to $2,790.2 million, compared to $1,248.4 million in the same period of 2024.
• The Marel acquisition contributed $536.5 million to Q3 2025 revenue and $1,462.0 million to nine-month 2025 revenue.
• Net income for Q3 2025 was $66.0 million, up 69.7% from $38.9 million in Q3 2024.
• Net loss for the nine months ended September 30, 2025, was $(103.6) million, a significant decline from a net income of $92.4 million in the same period of 2024.
• Adjusted EBITDA from continuing operations increased by 109.2% to $170.9 million in Q3 2025 and by 116.6% to $439.3 million for the nine months ended September 30, 2025.
• A pre-tax settlement charge of $146.9 million was recognized in the nine months ended September 30, 2025, due to the termination of the U.S. qualified defined benefit pension plan.
• The JBT Marel 2025 Integration restructuring plan's total estimated cost was revised from $25.0-$30.0 million to a range of $30.0-$35.0 million, with $24.1 million recognized through September 30, 2025.
• Material weaknesses were identified in Marel's internal control over financial reporting, specifically in IT general controls and journal entry review.

Sentiment

Score: 4

Explanation: While Q3 revenue exceeded expectations and Adjusted EBITDA grew significantly, the nine-month period shows a substantial net loss, primarily due to one-time pension settlement charges, increased interest expense from the Marel acquisition, and integration costs. The identified material weaknesses in Marel's internal controls also add a layer of concern. The long-term strategic benefits of the Marel acquisition are highlighted, but the immediate financial impact is negative.

Positives

• Achieved substantial revenue growth of 120.6% in Q3 2025 and 123.5% for the nine months ended September 30, 2025, largely driven by the Marel acquisition.
• Q3 2025 net income increased by 69.7% to $66.0 million, demonstrating strong quarterly performance.
• Adjusted EBITDA from continuing operations saw significant increases of 109.2% in Q3 2025 ($170.9 million) and 116.6% for the nine months ended September 30, 2025 ($439.3 million).
• Management reported that Q3 2025 revenue performance exceeded expectations, driven by higher book and ship revenue and improved manufacturing/supply chain productivity.
• Experienced strong demand in poultry, pharmaceutical, and pet food end markets.
• Selling, general and administrative expense as a percentage of revenue decreased by 240 bps in Q3 2025 due to better operating leverage from higher revenue and savings from the JBT Marel 2025 Integration restructuring plan.
• Free cash flow for the nine months ended September 30, 2025, was $163.0 million, an $83.8 million increase compared to the same period in 2024.
• Successfully executed cross-currency swap agreements to hedge foreign exchange risk and manage interest rates on debt, resulting in $3.1 million in other income in Q3 and $8.1 million in 9M 2025.
• The company expects to generate positive cash flows for the full year 2025.
• Secured takeout financing with an amended $1.8 billion revolving credit facility and a $900 million Senior Secured Term Loan B, and subsequently amended these to reduce pricing.

Negatives

• Reported a net loss of $(103.6) million for the nine months ended September 30, 2025, a significant reversal from a net income of $92.4 million in the prior year.
• Income from continuing operations for the nine months ended September 30, 2025, was a loss of $(102.8) million, a decrease of $194.3 million from income of $91.5 million in the prior year.
• Gross profit margin slightly decreased for the nine months ended September 30, 2025, to 35.4% from 35.8% in 2024, primarily due to a lower gross profit margin of the acquired Marel business.
• Selling, general and administrative expense increased substantially by $110.4 million in Q3 2025 and $428.4 million for the nine months ended September 30, 2025, primarily due to the Marel acquisition and integration costs.
• Research and development expense increased significantly by $23.3 million in Q3 2025 and $75.6 million for the nine months ended September 30, 2025, mainly due to the acquired Marel business.
• Pension expense, other than service cost, increased by $144.2 million for the nine months ended September 30, 2025, primarily due to a $146.9 million settlement charge from pension plan termination.
• Incurred a $10.6 million loss on investment during the nine months ended September 30, 2025, related to the exit of an investment due to the Marel acquisition.
• Interest expense increased significantly by $20.6 million in Q3 2025 and $87.8 million for the nine months ended September 30, 2025, driven by higher average debt balances and interest rates for the Marel acquisition.
• Income from continuing operations margin decreased by 170 bps in Q3 2025 and 1100 bps for the nine months ended September 30, 2025, due to higher integration costs, interest expense, pension expense, and loss on investment.
• JBT segment Adjusted EBITDA decreased by 12.7% in Q3 2025, attributed to tariff impacts, unfavorable mix, and project variances.
• The tax rate for the nine months ended September 30, 2025, was unfavorably impacted by $5.1 million from non-deductible acquisition costs and a non-deductible loss on investment.
• Identified material weaknesses in Marel's internal control over financial reporting, specifically in IT general controls and journal entry review, which remained unremediated as of September 30, 2025.

Risks

• Inability to successfully integrate the legacy businesses of JBT and Marel, operationally, technologically, culturally, or otherwise, to achieve anticipated benefits and synergies.
• Fluctuations in financial results.
• Changes to tariffs, trade regulation, quotas, or duties.
• Deterioration of economic conditions, including impacts from supply chain delays and reduced material or component availability.
• Unanticipated delays or accelerations in sales cycles.
• Inflationary pressures, including increases in energy, raw material, freight, and labor costs.
• Disruptions in the political, regulatory, economic, and social conditions of the countries in which business is conducted.
• The potential effects of the U.S. government shutdown that began in October 2025.
• Fluctuations in currency exchange rates and interest rates.
• Changes in food consumption patterns.
• Impacts of pandemic illnesses, foodborne illnesses, and diseases to various agricultural products.
• Weather conditions and natural disasters.
• The impact of climate change and environmental protection initiatives.
• Acts of terrorism or war, including the ongoing conflicts in Ukraine and the Middle East.
• Termination or loss of major customer contracts and risks associated with fixed-price contracts, particularly during periods of high inflation.
• Customer sourcing initiatives.
• Competition and innovation in industries.
• Ability to develop and introduce new or enhanced products and services and keep pace with technological developments.
• Difficulty in developing, preserving, and protecting intellectual property or defending claims of infringement.
• Catastrophic loss at any facilities and business continuity of information systems.
• Cyber-security risks such as network intrusion or ransomware schemes.
• Loss of key management and other personnel.
• Potential liability arising out of the installation or use of systems.
• Ability to comply with U.S. and international laws governing operations and industries.
• Increases in tax liabilities.
• Work stoppages.
• Ability to remediate the material weaknesses relating to the Marel financial statements.
• Availability of and access to financial and other resources.
• Fair value estimates for intangible assets are inherently uncertain and subject to refinement, and future changes in estimates could result in impairment charges.

Future Outlook

The company anticipates that its 2025 performance will be impacted by evolving tariff costs and is taking proactive measures such as reshoring suppliers, seeking vendor concessions, and adjusting pricing. It plans to realign its reportable segments in Q4 2025 into 'Protein Solutions' and 'Prepared Food and Beverage Solutions' to better reflect its integrated operating model. The company expects to generate positive cash flows for the full year 2025 and projects capital expenditures between $90 million and $95 million. Integration and synergy-related costs for the Marel acquisition are estimated to be in the range of $50 million to $60 million during 2025, with cumulative cost savings from the integration restructuring plan expected to be between $50.0 million and $60.0 million, with approximately $10.0 million of these savings expected in the remainder of 2025.

Management Comments

• "Our third quarter 2025 revenue performance exceeded expectations and was primarily driven by higher book and ship revenue coupled with improved manufacturing and supply chain productivity, which enabled increased backlog conversion, particularly in poultry."
• "We also delivered strong margins in the quarter as a result of volume leverage, a favorable mix of poultry equipment and shorter cycle products, and synergy savings."
• "Orders remained healthy with strong demand in poultry, pharmaceutical, and pet food end markets."
• "JBT Marel brings together the combined strengths of JBT and Marel with the goal of transforming the future of food."
• "We aim to create better outcomes for our diverse customers by optimizing food yield and efficiency, improving food safety and quality, and enhancing uptime and proactive maintenance, all while reducing waste and resource use across the global food supply chain."

Industry Context

The acquisition of Marel hf. on January 2, 2025, significantly transforms JBT into a leading and diversified global food and beverage technology solutions provider. This strategic move combines complementary product portfolios and technologies, positioning the company to capitalize on favorable trends in the food processing industry, such as demand for optimized food yield, improved safety, and reduced waste. The planned realignment of reportable segments into 'Protein Solutions' and 'Prepared Food and Beverage Solutions' in Q4 2025 further refines its market approach, allowing for more focused solutions across key industry verticals like poultry, meat, fish, pet food, and plant-based proteins, enhancing its competitive stance against other global food technology providers.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to global benchmarks for direct industry standard comparison.

Management Changes

Corporate Governance

Legal Proceedings

• Not currently a party to or aware of any legal proceedings that are believed to have, individually or in the aggregate, a material adverse effect on the business, financial condition, or results of operations.

Related Party Transactions

• The company is a party to lease agreements for manufacturing facilities from entities owned by certain employees who were former owners or employees of acquired businesses. As of September 30, 2025, the operating lease right-of-use asset was $2.4 million and the lease liability was $2.5 million.

Stakeholder Impact

• Shareholders: Experienced a net loss for the nine-month period, impacting earnings per share, but received cash dividends. Potential for future value creation from the Marel integration and synergy targets. Potential for dilution from warrants if the stock price exceeds the strike price.
• Employees: Restructuring plans involve employee separation benefits. The company emphasizes inclusive leadership and diverse hiring practices. The U.S. qualified defined benefit pension plan was terminated and settled.
• Customers: Benefit from the combined entity's expanded portfolio of technology solutions aimed at optimizing food yield, efficiency, safety, and reducing waste. Strong demand noted in poultry, pharmaceutical, and pet food end markets.
• Creditors: Increased debt levels due to the Marel acquisition, but the company is in compliance with all debt covenants. Amendments to credit agreements have reduced pricing, potentially lowering future interest costs.
• Suppliers: Proactive measures are being taken to mitigate tariff impacts, including reshoring third-party suppliers and seeking vendor concessions, which may affect supplier relationships and sourcing strategies.

Next Steps

• The company plans to realign its reportable segments to Protein Solutions and Prepared Food and Beverage Solutions during the fourth quarter of 2025.
• The segment realignment will be reflected in the December 31, 2025 Annual Report on Form 10-K, with prior periods recast.
• The company continues to complete the provisional purchase accounting for Marel, with valuations of certain assets and liabilities subject to change within the 12-month measurement period.
• Remaining costs for the JBT Marel 2025 Integration restructuring plan are expected to be recognized by the end of 2026.
• The company is evaluating the impact of adopting recently issued accounting standards (ASU 2023-09, ASU 2024-03, ASU 2025-05, ASU 2025-06).
• The company will continue to evaluate the current and future period effects of the OBBB tax law as additional information becomes available.
• Remediation activities are in progress to address identified material weaknesses in Marel's internal controls over financial reporting.

Key Dates

Recommendation

The Marel acquisition significantly expands JBT's market presence and revenue, positioning it for long-term growth in the food and beverage technology sector. However, the immediate financial impact includes a substantial nine-month net loss driven by one-time pension settlement charges, increased interest expense from acquisition debt, and integration costs. While Q3 revenue exceeded expectations and Adjusted EBITDA shows strong growth, the identified material weaknesses in Marel's internal controls add a layer of operational risk. The company is actively managing debt and integration, but the full benefits and successful remediation of control issues are still in progress. A 'Hold' recommendation reflects the long-term strategic potential balanced against the short-to-medium term financial headwinds and integration challenges.

Keywords

Food processing, Beverage technology, Marel acquisition, Financial results, Q3 2025, 10-Q, SEC filing, JBT Marel, Food and beverage industry, Corporate governance, Risk management, Financial reporting, Integration, Restructuring, Convertible notes, Debt, EBITDA, Net income, Supply chain, Tariffs, Internal controls